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Abstract   
The primary aim of this exploratory study was to analyse the design factors contributing to the 
reading ease and comprehension of medicinal information leaflets.  Good practice guidelines 
on general typography and layout were chosen from the literature and compared with European 
Commission guidelines on preparing package leaflets. The suitability of the guidelines for 
evaluating package inserts was investigated using leaflets accompanying thirteen different 
medicines available from pharmacies.  With minor revision, the design recommendations were 
appropriate for developing over the counter medicinal leaflets. There was general agreement 
that simplicity is the key to good information design.  It was concluded that the design of 
readable medicinal package inserts is a complex, process.  Consumer participation is essential 
and advice from a professional designer highly desirable.  
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Introduction 
Patients are being encouraged by recent government initiatives to take greater personal 
responsibility, in partnership with appropriate professionals, for health care decisions 
(Department of Health, 1997a; 2000). Consumer choice has increased in the last decade with 
legislative action allowing a wider range of more potent medicines previously only available on 
prescription being reclassified for sale in pharmacies (Blenkinsopp & Bradley, 1996).  Access 
to high quality information is essential if these drugs are to be used safely and effectively 
without clinical supervision.  
 
 Since 1998 all UK medicinal products, whether dispensed by a pharmacist or bought over the 
counter, have to be supplied with an authorised patient information leaflet (European 
Commission, 1992; Medicines Control Agency, 1998a).  Manufacturers need to compile 
leaflets that comply with this legislation, fit into the drug packaging and are understood by a 
general population with diverse abilities and needs (Griffin & Griffin, 1996).  The few studies 
that have evaluated the quality of medicinal package inserts (Bradley, 1994; Wong, 1999) have 
used readability formulae as assessment tools but these are limited in their scope for improving 
  
the quality and value of information leaflets (Redish, 1981).  Information design not only 
improves the presentation of a document, it is also instrumental in attracting, motivating and 
promoting the understanding of the reader (Orna & Stevens, 1991).  
 
In this exploratory study good practice design guidelines have been compiled from the 
literature and used to assess a sample of patient information leaflets (PIL) supplied with over 
the counter (OTC) medicines in the United Kingdom.  As far as is known this is the first study 
to investigate the design of OTC medicinal package inserts. 
 
 
Methodology 
Guidelines on information design from the literature were pooled and areas of consensus and 
dissimilarity identified.  A set of evaluated guidelines was compiled and compared to: 
• the guideline on the readability of the package leaflet produced by the European 
Commission (1998) 
•  a sample of current OTC medicinal information leaflets. 
 
Literature searches  Between October 1998 and February 1999, searches were made using 
MEDLINE, PsycLIT, LISA Plus, Science Citation Index of BIDS and the Internet.  Free text 
and subject heading searches were conducted covering:  medicines, patient information leaflets, 
health education, information and product design, communication, guidelines, evaluation 
studies, patient satisfaction and quality indicators.  Investigation of hyperlinks and the reference 
sections of articles from initial results gave additional sources.  Guidelines based on research 
evidence, the psychology of reading and the practice of graphic designers were selected.  
Wherever possible the original source of the guidelines was traced so that agreement amongst 
authors was not spurious.   
 
Patient information leaflets  Leaflets accompanying products whose legal status had changed 
from prescription only to pharmacy sale since 1993 were chosen for analysis.  The starting date 
was selected as the time when the Medicines Control Agency (MCA) introduced a new 
structured annual timetable to expedite the reclassification of prescription only medicines 
(Department of Health, 1994).  The products containing single active substances were 
identified from the Chief Medical Officer’s Annual Reports (Department of Health, 1994; 
1995; 1996; 1997b; 1998) supported by information from the MCA (1997, 1998b) and its 
advisers (Lawson, 1996).  Package inserts were obtained from a retail pharmacist, photocopied 
and details, such as size and colour that did not show on the photocopies, recorded. 
 
Leaflet characteristics  The leaflets were assessed as follows: 1) linear measurements were 
made by eye to the nearest 0.5mm using a millimetre rule; 2) transparency was registered when 
print from the reverse side showed through the leaflet; 3) type size was estimated from the text 
occupying the majority of the leaflet.  Measurement was made in millimetres, from the top of 
an ascender of a letter to the bottom of a descender in one line, and converted to ‘points’ (1mm 
is approximately equivalent to 3 points); and 4) typefaces were identified by comparison to 
typographic encyclopaedias (Jaspert, 1970; V & M Typographic, 1974).  
 
 
Information Design Guidelines 
Good design practice identified from the literature originated from a range of organisations and 
researchers with differing backgrounds and interests: Association of the British Pharmaceutical 
Association (1990); Basic Skills Agency (1999); Hartley (1994, 1998, 1999); National 
Information Forum (1996); Orna and Stevens (1995); Plain English Campaign (1998); Raynor 
(1992); Royal National Institute for the Blind (1997); and Stone (1992).  The benchmark 
  
criteria shown in Table 1 were formulated with the general reader in mind, as OTC medicines 
are available to all members of the public.  In particular, the advice of the Basic Skills Agency 
(1999) and the Royal National Institute for the Blind (1997) was heeded to include visually 
impaired and older people and those with reading difficulties.  Simplicity, clarity and the 
importance of planned spacing are emphasised in the literature.  The choice and orientation of 
page size and the inclusion of illustrations will determine many of the subsequent design 
decisions (Hartley, 1999).  However, once the format, spacing (between headings, paragraphs 
and lines) and typographic or colour cues have been chosen they must be used consistently 
throughout the leaflet (Hartley, 1994; Orna & Stevens, 1995).  Significant differences between 
authors were only revealed in two areas: type size and justification of text.   
 
  
Table 1: Good practice guidelines on patient leaflet design and typography 
 
 
Paper 
 
A5 size is preferable A leaflet is more likely to be 
kept if it is a convenient size e.g. able to fit in a 
medicine bag or pocket  
 
Non-transparent paper Text showing through from 
the reverse side makes letters and words difficult to 
distinguish  
 
Matt surface Glossy paper makes reading difficult 
by reflecting too much light  
 
Layout 
 
Consistent use of layout Consistent organisation 
within the leaflet gives visual clues to the proximity 
and grouping of textual elements and headings  
 
Plenty of white space A page of close-set type 
easily daunts readers and there is a long tradition in 
design that the 4 margins are never equal in width  
 
Clear separation of columns When space is 
limited clearly separating columns of text, including 
using vertical rules, can help reading  
 
Typography 
 
 
12-point minimum type size Twelve-point text 
produces documents intended for general readers  
 
Conventional typefaces The general public is 
familiar with such typefaces, that are clear and 
legible when printed and copied  
 
 
Not more than 2 typefaces One face for the text 
and one for the captions is less confusing for the 
reader  
 
 
Interline spacing of 125% of 12-point type (5mm) 
Strips of white space between lines help the eye to 
separate one line from another; 125% of the type 
size as the line space avoids the text looking 
cramped and crowded but any wider than this 
makes the lines appear to float apart  
 
Avoid unnecessary capitals Lower case letters 
give shape to words and so are easier to recognise 
and read than all upper case  
Unjustified right-hand margins An overall even 
texture helps reading by allowing the eye to link 
words together and is best achieved using 
unjustified text  
 
 
Maximum line length of 50-65 characters or 8-11 
words Very short lines break up sentences too 
much; long lines tend to lose attention  
 
Text should not be wrapped around illustrations 
This can result in unaligned left-hand margins and 
very short line lengths  
 
Text should not be printed over pictures Over 
printing of pictures, especially if a dark background 
is used, makes reading very difficult as it limits 
contrast and confuses the eye  
 
Headings 
 
Consistent use of headings This aids readability 
and location of information by clearly differentiating 
between groups of related items  
 
Table of contents desirable This helps to locate 
specific instructions or explanations and can be a 
very important aid in a long leaflet  
 
Numbered headings recommended These help 
cross-referencing and avoid repetition  
 
Bullet points recommended This format is clearer 
for sequential information  
 
Bold or boxed in type for emphasis This is 
preferable to all upper case and multiple cueing 
systems can be confusing  
 
Colour 
 
Black print on a white background This gives the 
best contrast and greatly enhances readability 
especially for people with visual impairment 
 
One extra colour, if used, for headings This can 
be helpful, if used consistently and the contrast with 
the background maintained, to emphasise headings 
 
 
Yellow should not be used The appearance of 
yellow printing ink is as good as invisible to visually 
impaired people  
  
 Type size  Ensuring the suitability of type for a particular audience has long been a main 
principle of typography (Orna & Stevens, 1995).  The Royal National Institute for the Blind 
(1997) uses 12-point text to produce documents intended for general readers and believes 
others should aspire to this level of print size, in agreement with the National Information 
Forum (1996).  Independent studies reviewed by Hartley (1999) have shown that a type size 
of 12- or 14-point is helpful to older readers.  A minimum of 14-point is advised for materials 
aimed at partially sighted and blind people, a significant proportion of whom can read large 
print (Royal National Institute for the Blind, 1997) but use of this size could make the PIL 
appear too long for the ‘average’ reader.  Additionally, according to the Basic Skills Agency 
(1999) too large a print can deter adults with reading difficulties as the material may look as 
though it is intended for children.  Therefore, 12-point type size has been adopted as a 
benchmark in this study. 
 
Justification  Justified text (straight edged left and right margins) causes ‘rivers’ of white 
space to appear as the gaps between words are adjusted to fill the line length so the eye has 
difficulty linking words together and slows down reading (Orna & Stevens, 1995).  Thus, the 
Royal National Institute for the Blind (1997) prefers unjustified text (jagged right-hand 
margin).  Although Hartley (1999) asserts that research suggests there is little to choose 
between the two and is largely a matter of style, he does concede that unjustified text is 
probably more flexible for information leaflets.  Therefore unjustified right-hand margins has 
been used as the standard in this study. 
 
Official guidelines   
Advice given by the regulators on page size, paper type, headings and emphasis (EC, 1998) 
does not differ significantly from the literature guidelines with two main exceptions.  The EC 
(1998) recommends the rather low minimum of 8-point type and this affects their advice on 
inter-line spacing (at least 3mm).  It is also suggested that sentences with more than 20 words 
should be avoided and lines with more than 70 characters not used but the basis for these 
statements is not referenced.  However, authoritative sources (Orna & Stevens, 1995; Plain 
English Campaign, 1998; Royal National Institute for the Blind, 1997) recommend more 
moderate line lengths for ease of reading, even in continuous text, leading to the guidance in 
Table 1.  The authorities (EC, 1998) give no or very general advice on margins, white space, 
column widths, paragraph spacing, typefaces and justification.  The official directions 
regarding illustrations are limited.  They are allowed only in addition to text if they help 
understanding and they must not be promotional.    
 
 
Package insert case studies 
Nineteen prescription medicines containing different active ingredients were identified as 
having changed legal status to pharmacy sale between 1993 and 1998.  Photocopies of 
package inserts were obtained for thirteen medicines whose details are shown in Table 2.  The 
other PILs were not available because the pharmacist who provided the leaflets did not stock 
two of the products, did not know the legal status had changed in one case and could not open 
three packs as they had security seals. 
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Table 2: Characteristics of over the counter medicinal package information leaflets    
 
 
Trade name 
 
Active ingredient TREATMENT 
USES 
Legal status 
change date* 
 
Leaflet 
date♦ 
     
Adcortyl in 
Orabase paste 
 
triamcinolone 
acetonide  
 
mouth ulcers 1994 Nov 1994 
Corlan pellets hydrocortisone 
sodium succinate  
 
mouth ulcers 1994 Jan 1994 
Diflucan One 
capsule 
 
fluconazole vaginal thrush 1995 Jun 1997 
 
Feldene P gel 
 
piroxicam pain relief  
 
1994 Oct 1996 
Motilium 10 
tablets 
domperidone  
maleate  
 
stomach queasiness, 
bloating, heartburn 
 
1998 Jun 1998 
Nizoral shampoo 
 
ketoconazole dandruff 
 
1995 Jul 1997 
Pepcid AC Acid 
Control tablets 
famotidine  heartburn, dyspepsia, 
excess acid 
 
1993 Jan 1996 
Rhinolast nasal 
spray 
azelastine 
hydrochloride 
 
hayfever 1996 Nov 1996 
Solpaflex gel ketoprofen  
 
reduction of pain and 
swelling  
 
1993 Apr 1996 
Syntaris nasal 
spray 
 
flunisolide hayfever 1995 Dec 1995 
Tagamet 100 
tablets 
cimetidine heartburn, dyspepsia, 
excess acid 
 
1993 Aug 1995 
Traxam gel felbinac  reduction of pain and 
swelling   
 
1994 Aug 1995 
Zovirax cream 
 
aciclovir  cold sores 1993 Sept 1996 
 
 
*Denotes year when the legal change to pharmacy sale was made; the product was not 
necessarily marketed in the same year 
♦This is the date of the leaflet included in the package at the time of the study (1999) 
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Page and paper characteristics  All the leaflets were printed on single sheets but had a wide 
range of dimensions.  Most (9/13) were close in area to A5 whilst the remainder were smaller.  
There was some correlation between the area of the leaflet and the pharmaceutical form and 
quantity of the product.  For example, one of the smallest products, Adcortyl 5g paste, 
contained a leaflet half the area of the insert supplied with one of the largest products, Nizoral 
60ml shampoo.  However, very similar products, e.g. Feldene and Solpaflex, had very 
different size leaflets indicating other factors were influencing the dimensions of the insert.  
Four leaflets were transparent but the measure used in this study was rather insensitive so this 
figure may increase when the original leaflets are viewed.  All the PILs had a matt surface. 
 
Layout  Formats were used consistently except where illustrations were included.  To 
maximise the use of space, the format had to vary in the Rhinolast, Syntaris, Traxam and 
Zovirax leaflets to accommodate text that related directly to the diagrams.  Two thirds (10/13) 
of the leaflets had a portrait style orientation and most (6/10) of these used a single-column 
text only format, as Hartley (1999) found with prescription PILs.  In other leaflets with 
diagrams, one used landscape and two used portrait.  The sample is too small to confirm the 
conclusion of Hartley (1999) that landscape orientation is more likely to be used when there is 
a need for illustrations and two-column text. 
 
Separation between columns was judged to be adequate ranging from 4 to 6mm. This is 
equivalent to 2-3 times the total type size although this was small (point 6-7) in this group of 
PILs.  Vertical lines were not used to separate columns in any of the relevant leaflets.  
Margins could not be measured as these did not show clearly enough on the photocopied 
leaflets.  Additionally, whether the amount of white space was adequate is probably a matter 
of opinion, best resolved by evaluation of the original PILs with consumers and graphic 
designers. 
 
Type size  No leaflets had type as large as 12-point although two (Nizoral and Feldene) had 
11-point type.  Four had 8 to 10-point and seven had 6 to 7-point type.  Thus, half of the 
leaflets used a print size lower even than the EC guidelines (1998).  However, all the leaflets 
were prepared before these guidelines became effective in January 1999.  Two leaflets with 6-
point type were about half A5 size and accompanied small volume products (Adcortyl and 
Corlan) used for mouth ulcers.  Increasing the area of these PILs to allow larger type may be 
difficult due to the small size of their packaging.  The remaining PILs that had very small type 
contained illustrations. 
 
Typeface  None of the PILs had bizarre, unusual or indistinct typefaces.  Nearly all the 
leaflets (12/13) use normal type for most of the text and the bold version for the headings.  
Nonetheless, this applies to typeface only and does not reflect the less simple use of colour, 
capitals and boxing used in some PILs.  
 
Inter-line spacing  None had an inter-line space of 5mm or more but the spaces used were all 
related to the print size and consistent with the 125% rule of thumb.  All the PILs had 
unjustified right-hand margins.  This is probably the best solution for these leaflets, as they do 
not contain much prose text and the sense often demands short lines. 
 
Line lengths  The line lengths for each sample leaflet varied considerably so the length of the 
longest line in each leaflet was taken as a very rough measure.  Most (9/13) PILs that had 
single columns of text had much longer lines (range 13-20 words; 68-132 characters) than the 
recommendation for prose text (8-11 words; 50-65 characters).  Two single column PILs 
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came within the advised range but one was a long narrow leaflet (Diflucan) and the other 
(Feldene) had one of the largest type sizes (11-point).  The remaining leaflets falling within 
the recommended range had two columns of text (Pepcid and Traxam).  
 
Headings  As for prescription drug leaflets (Patient i, 1997), the majority of the leaflets 
(10/13) used left-ranging headings with the remainder having centred ones.  Most inserts had 
two or less headings and used typographic and colour cues consistently.  However, this is not 
as simple as it sounds.  Seven PILs had obvious headings that were clearly distinguishable 
from the text.  Others had consistent use of headings but multiple cueing systems, using a 
combination of bold and italic print with variations of colours, capitals and boxing, which 
appeared confusing.  In others, similar devices were used for emphasis of important 
information and it was difficult to differentiate these from the headings.  There was no 
obvious connection between the use of ‘complex’ headings and the treatment uses of the 
medicines. These PILs were prepared only slightly earlier (median 1995) than those with 
‘simple’ headings (median 1996). 
 
The newest leaflet, Motilium prepared in June 1998, was the only one to have numbered 
headings whilst none had a table of contents. This is not surprising since this advice from the 
European Commission (1998) post-dates all of the PILs.  Bullet point summaries were present 
at some point in nearly all of the leaflets (10/13) although they were only used extensively in 
two (Motilium and Syntaris).  Eight PILs had bullet points for the ‘precautions’ section only.   
 
Emphasis  Capitals were used in almost half the leaflets for headings (6/13) and three had 
complete sentences in capitals to indicate warnings.  As research suggests lower case letters 
are easier to read (Hartley, 1994), manufacturers would be wise to avoid unnecessary capitals 
for important information and for long headings (European Commission, 1998).  All the 
leaflets had bold headings. 
 
The text of two PILs (Feldene and Nizoral) did not contain any emphasised areas.  In the 
remainder attention was drawn to the content in the following ways (number of leaflets in 
brackets): bold type (11), capitals (7), boxing (5), colour (4), underlining (2) and italic type 
(1).  However, only three PILs had simple devices.  Some had quite complex arrangements; 
for example, boxing, colour, bold type and capitals highlighted single warnings in the 
Rhinolast and Syntaris leaflets.  The product name was printed in capitals or bold type in five 
leaflets.  This may not accord with minimisation of the brand name as indicated by the EC 
(1998).   
 
Colour  All the leaflets except one had a white background.  Most (8/13) had black print on 
white paper whilst four had royal blue print.  The Diflucan leaflet had a two-tone blue 
background and purple print, probably the worst combination for making reading difficult 
(Basic Skills Agency, 1999).  Only the Rhinolast and Zovirax leaflets had another colour 
typeface and this was reserved for the headings.  However, since the headings were also 
printed in bold type or boxed, an extra colour, of whatever hue, is possibly unnecessary.  
Yellow ink was used in the headings and illustrations in two leaflets (Traxam and Syntaris) 
counter to the advice of the Royal National Institute for the Blind (1997). 
 
Illustrations  None of the PILs were printed over pictures or had text wrapped around the 
illustrations.  Six PILs had illustrations: three using diagrams, two using pictograms and one 
using both.   
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Using the guidelines 
The guidelines were developed with the aim of helping to produce planned, simple and clear 
documents focused on the needs of users.  Using the study PILs allowed these guidelines to be 
revised to accommodate the particular circumstances of package inserts: 
• the advice given for maximum line length was difficult to apply since the length of 
lines in the leaflets varied considerably  
• consistency in the use of headings alone did not always help the appearance of a 
document.  Therefore, this advice should be extended to include headings clearly 
differentiated from the text in accordance with simplicity (Hartley, 1999).  
 
The designs ranged from ‘simple’ ones that mainly followed the guidelines to much more 
complex arrangements. For example, the PIL for Feldene (pain relief gel) had 11-point type 
and simple bold headings clearly differentiated from the text.  Black instead of blue print and 
bullet points may improve its readability.  The insert for Syntaris (for hayfever) was much 
more complex with 7-point type, more than two typefaces, sentences in italic and wide use of 
capitals, bold type, boxing and colour. Although this leaflet contains possibly useful diagrams 
on how to use the nasal spray it could still be simplified by following the guidelines. 
 
 This investigation was essentially exploratory and did not expect to reach overall conclusions 
on the design success, or otherwise, of OTC medicinal leaflets.  However, small changes in 
some PILs could be tested with consumers immediately.  Reducing the very large symbol that 
dominates the first page would considerably shorten the Tagamet leaflet.  Yellow ink used in 
the headings and illustrations in the Traxam and Syntaris inserts could be replaced with a 
darker colour to increase readability.  None of the leaflets examined displayed the Crystal 
Mark awarded by the Plain English Campaign (1998) as a guarantee of a document’s clarity 
of design as well as clearly and plainly written text.  It is unknown whether the 
pharmaceutical companies involved had applied for the award.   
 
Discussion 
There was general agreement amongst those committed to communicating information to 
members of the public of the fundamentals of good design.  Although Orna and Stevens 
(1991, 1995) state that the principles of typographic design are based on well-founded 
research, the evidence base for the guidelines reported here requires systematic review.  
However, this should be undertaken within the context of document design being mainly a 
problem-solving task operating within the constraints of content, space, time and budget.  The 
skill and flair of a professional designer may be required whilst organisations such as the 
Plain English Campaign (1998) offer guidance on communicating clearly and effectively.  
However, the final decisions should be based on consumer evaluation. 
 
The benchmarks were chosen so that the design of the leaflet made it accessible to as many 
people as possible including older people and those with literacy problems. They will not 
cater for non-English speakers, many blind consumers and people with learning difficulties.  
It would be impractical to expect manufacturers to supply leaflets for all these groups in the 
packaging but some mechanism allowing access to drug information for these members of 
society needs investigation. 
 
This study raised the difficulty of obtaining leaflets accompanying OTC medicines, whether 
the originals or copies, without expense or personal contacts.  A widely available 
compendium of OTC package inserts as exists for prescribed medicines (Walker, 1999) would 
benefit consumers as well as health professionals.  PILs could not be obtained for six products 
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but the sample assessed represented the main reasons consumers use an OTC medicine 
(Blenkinsopp & Bradley, 1996) and a range of manufacturers.  
 
Although the sample of PILs produced by OTC manufacturers was very varied, the pooled 
published guidelines were generally suitable for assessing the design of drug package inserts.  
However, the recommendation of a maximum line length of 50-65 characters was not easily 
applied to this type of leaflet.  Some guidance on line length is needed but it is dependent on 
the initial choice of layout, such as single or double columns of text.  Newton et al. (1998) 
found that single column text was preferred to newspaper-style columns in a leaflet on gout 
but further investigation is required with package inserts.  Examination of the sample leaflets 
also showed that headings need to be used not only consistently but also clearly separated 
from the text if they are to act as good navigational aids.   
 
The advice to use ‘plenty of white space’ was kept in the guidelines although it is difficult to 
assess and is probably best determined by consulting consumers and designers.  A better 
indicator for the measure of transparency than the one used in this study would be the weight 
of the paper (g/m2), given the availability of appropriate weighing equipment.  The EC (1998) 
recommends a minimum weight of 40g/m2 statement but the opacity of this weight requires 
confirmation.  However, thicker paper may make the PILs more difficult to fold and fit into 
the packs. 
 
Overall, this study confirmed previous advice (Basic Skills Agency, 1999; Hartley, 1994; 
Orna & Stevens, 1995; Royal National Institute for the Blind, 1997) that the initial choice of 
page size and the decision to include diagrams is important since it affects many subsequent 
design characteristics, especially type size.  About half the inserts did not follow the 
recommendations for simplicity and clarity.  Considerable variation in size, shape, typography 
and layout was evident in the sample OTC leaflets, confirming previous findings with 
prescription medicine leaflets (Hartley, 1999). None of the sample had a type size as large as 
that recommended by the Royal National Institute for the Blind (1997) for adult readers. 
However, increasing type size, and associated inter-line spacing, would make the PIL longer.  
Type size, the usefulness of illustrations and the devices used to emphasise headings and 
warnings require further investigation with consumers to establish best practice.  The EC 
(1998) has indicated that it is open to making changes in the legislation if they are shown to 
improve readability. 
 
Conclusions  
Production of patient package inserts is a complex, process requiring regulatory approval.  As 
this is the first study to investigate the design of OTC medicinal package inserts more 
questions than answers were raised. The following areas would benefit from more detailed 
research: 
• the evidence underpinning the guidelines compiled in this study  
• evaluation by consumers of the readability of PILs revised using the good design 
guidelines  
• user preference regarding the style of layout and typography, especially type size, 
and the use of illustrations in medicinal package inserts and the consequent effects 
on comprehension   
• the effect of consumer involvement on the design of medicinal PILs  
• the value for pharmaceutical companies of consulting a professional information 
designer and the Plain English Campaign when drafting package inserts 
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Following establishment of the most effective layout and typography, approaches should be 
made to the European Commission and Medicines Control Agency to supplement or change 
the guidance given to manufacturers for the preparation of patient information leaflets.  Good 
information design is important but attention to this alone does not produce high quality 
patient information leaflets.  Well written text, evidence-based information and consumer 
testing are also essential. 
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